Citation: | YE Nan, CHANG Ting, HE Xiaoli, SHAO Jinhua, LIU Xin, GUO Rongjing. Clinical manifestations, cerebrospinal fluid and imaging features of myelin oligodendrocyte glycoprotein antibody-related diseases[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 103-107. DOI: 10.7619/jcmp.202020029 |
SATO D K, CALLEGARO D, LANA-PEIXOTO M A, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders [J]. Neurology, 2014, 82(6): 474-81.
|
JARIUS S, PAUL F, AKTAS O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing [J]. J Neuroinflammation, 2018, 15(1): 134-138.
|
LOPEZ-CHIRIBOGA A S, MAJED M, FRYER J, et al. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders [J]. JAMA Neurol, 2018, 75(11): 1355-63.
|
JARIUS S, RUPRECHT K, STELLMANN J P, et al. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature [J]. J Neuroinflammation, 2018, 15(1): 88-94.
|
HYUN J W, HUH S Y, SHIN H J, et al. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis [J]. Mult Scler, 2019, 25(4): 585-590.
|
HOFTBERGER R, GUO Y, FLANAGAN E P, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody [J]. Acta Neuropathol, 2020, 139(5): 875-892.
|
JARIUS S, RUPRECHT K, KLEITER I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome [J]. J Neuroinflammation, 2016, 13(1): 280-286.
|
COBO-CALVO A, RUIZ A, MAILLART E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study [J]. Neurology, 2018, 90(21): e1858-e1869.
|
崔东清, 左瑶, 刘燕霞, 等. 髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床及影像学特点 [J]. 中华神经科杂志, 2020, 53(1): 19-24.
|
DOSPASSOS G R, OLIVEIRA L M, DACOSTA B K, et al. MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder[J]. Front Neurol, 2018, 9: 217-222.
|
洪姗燕, 王凌星, 杨美丽, 等. MOG抗体介导的单侧皮质脑炎1例报告 [J]. 中国神经精神疾病杂志, 2019, 45(6): 382-384.
|
DENEVE M, BIOTTI D, PATSOURA S, et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults [J]. J Neuroradiol, 2019, 46(5): 312-318.
|
SEPULVEDA M, ARMANGUE T, MARTINEZ-HERNANDEZ E, et al. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes [J]. Journal of neurology, 2016, 263(7): 1349-1360.
|
GRANGEON L, HÉBANT B, GUILLAUME M, et al. Myelitis with normal spinal cord MRI: don't forget anti-MOG antibodies disease![J]. Acta Neurol Belg, 2020, 120(4): 945-946.
|
LI K, ZHAN Y, SHEN X. Multiple intracranial lesions with lung adenocarcinoma: a rare case of MOG-IgG-associated encephalomyelitis[J]. Mult Scler Relat Disord, 2020, 42: 102064.
|
JARIUS S, RUPRECHT K, KLEITER I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin [J]. J Neuroinflammation, 2016, 13(1): 279.
|
李虹, 王红芬, 王湘庆. 巨细胞病毒感染相关抗髓鞘少突胶质细胞糖蛋白抗体阳性的急性播散性脑脊髓炎一例 [J]. 中华神经科杂志, 2018, 51(6): 473-476.
|